Evidence map›Paper›PMID 32867397›Full record

ArticleMarine drugs2020

Antimicrobial Chlorinated 3-Phenylpropanoic Acid Derivatives from the Red Sea Marine Actinomycete

Lamiaa A Shaala, Diaa T A Youssef, Torki A Alzughaibi, Sameh S Elhady

Abstract read
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Advances in the Study of Halogenated Natural Products.Current topics in medicinal chemistry · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Naturally Occurring Organohalogen Compounds-A Comprehensive Review.Progress in the chemistry of organic natural products · 2023
    Review
  11. Review
  12. Marine Compounds with Anti-Journal of fungi (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lamiaa A ShaalaNatural Products Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-1866-8258
Diaa T A YoussefDepartment of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-2217-4039
Torki A AlzughaibiDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-2855-5134
Sameh S ElhadyDepartment of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-3799-0581

Funding

Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, under grant No. (G-270-141-39). G-270-141-39
6 · The paper itself

Abstract

The actinomycete strain

Indexed as

AnimalsAnti-Bacterial AgentsAntifungal AgentsCallyspongiaCandida albicansEscherichia coliIndian OceanMicrobial Sensitivity TestsMolecular StructurePhenylpropionatesStaphylococcus aureusStreptomyces coelicolorStructure-Activity Relationship3-phenylpropionic acidAnti-Bacterial AgentsAntifungal AgentsPhenylpropionatesantimicrobial activitiesdiketopiperazine alkaloidshalogenated 3-phenylpropanoic acid derivativesmarine actinomycetesRed Sea spongesStreptomyces coelicolor LY001structural determinations

Identifiers

PMID32867397
PMCPMC7551466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.